21 Oct ACG 2022 Annual Scientific Meeting, Charlotte, North Carolina

ASX:RHT

WPDesigns

Introducing Liversmart: A New Ai Medical Device

Resonance Health Ltd announces the development of its newest AI medical device, LiverSmart, which is now undergoing final quality and verification checks prior to its submission to the United States Food & Drug Administration (FDA) for regulatory clearance.

LiverSmart combines two existing regulatory-cleared Resonance Health products, FerriSmart® and HepaFat-AI®, into a single multi-parametric MRI session, avoiding the need for multiple MRI appointments, and delivering a more complete and comprehensive assessment of a person’s liver.

Introducing LiverSmart: A New AI Medical Device

Resonance Health Ltd announces the development of its newest AI medical device, LiverSmart, which is now undergoing final quality and verification checks prior to its submission to the United States Food & Drug Administration (FDA) for regulatory clearance. LiverSmart combines two existing regulatory-cleared Resonance Health products, FerriSmart® and HepaFat-AI®, into a single multi-parametric MRI session, …

Introducing LiverSmart: A New AI Medical Device Read More »

ACG 2021 Annual Scientific Meeting

8 October 2021 ACG 2021 Annual Scientific Meeting, American College of Gastroenterology Mandalay Bay, Las Vegas  Resonance Health will be attending the ACG 2021 Annual Scientific Meeting and Postgraduate Course hosted by the American College of Gastroenterology on 22-27 October 2021.